SCNI — Scinai Immunotherapeutics Share News
0.000.00%
Last trade - 00:00- $0.02m
- $3.28m
- $1.31m
BiondVax Pharma: U.S. shares plunge as flu vaccine fails to meet efficacy goals
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:52 AM
NASDAQ RESUMED AT 11:52 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:48 AM
NASDAQ RESUMED AT 11:32 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:27 AM
NASDAQ RESUMED AT 11:27 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:22 AM
NASDAQ RESUMED AT 11:21 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:11 AM
NASDAQ RESUMED AT 11:11 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 09:12 AM
Brief: Biondvax Pharmaceuticals Ltd Files For Stock Shelf Of Upto $150 Mln
Brief: BiondVax - Last Of 12,400 Participants Completes Final Visit In Biondvax's M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial
NASDAQ RESUMED AT 08:37 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 08:34 AM
NASDAQ RESUMED AT 11:13 AM
NASDAQ RESUMED AT 10:39 AM